153 related articles for article (PubMed ID: 29805537)
1. Contribution of susceptibility- and diffusion-weighted magnetic resonance imaging for grading gliomas.
Xu J; Xu H; Zhang W; Zheng J
Exp Ther Med; 2018 Jun; 15(6):5113-5118. PubMed ID: 29805537
[TBL] [Abstract][Full Text] [Related]
2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
[TBL] [Abstract][Full Text] [Related]
4. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
[TBL] [Abstract][Full Text] [Related]
5. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
7. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
8. Grading Gliomas Capability: Comparison between Visual Assessment and Apparent Diffusion Coefficient (ADC) Value Measurement on Diffusion-Weighted Imaging (DWI).
Phuttharak W; Thammaroj J; Wara-Asawapati S; Panpeng K
Asian Pac J Cancer Prev; 2020 Feb; 21(2):385-390. PubMed ID: 32102515
[TBL] [Abstract][Full Text] [Related]
9. [Application of susceptibility weighted imaging in revealing intratumoral blood products and grading gliomas].
Zhang W; Zhao J; Guo D; Zhong W; Shu J; Luo Y
J Radiol; 2010 Apr; 91(4):485-90. PubMed ID: 20514004
[TBL] [Abstract][Full Text] [Related]
10. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
[TBL] [Abstract][Full Text] [Related]
11. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas.
Wu CC; Guo WY; Chen MH; Ho DM; Hung AS; Chung HW
J Chin Med Assoc; 2012 Nov; 75(11):581-8. PubMed ID: 23158036
[TBL] [Abstract][Full Text] [Related]
12. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
[TBL] [Abstract][Full Text] [Related]
13. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
14. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging.
Wang C; Dong H
Acta Radiol; 2020 Aug; 61(8):1057-1063. PubMed ID: 31830431
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling in Ki-67 labeling index and grading of brain gliomas].
Wang CC; Dong HB; Ding F; Li YD; Wang GY; Ding HX
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):338-342. PubMed ID: 30772973
[No Abstract] [Full Text] [Related]
17. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
18. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
20. The Added Value of Inflow-Based Vascular-Space-Occupancy and Diffusion-Weighted Imaging in Preoperative Grading of Gliomas.
Cao H; Xiao X; Hua J; Huang G; He W; Qin J; Wu Y; Li X
Neurodegener Dis; 2020; 20(4):123-130. PubMed ID: 33735873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]